Antisense Oligonucleotides in the Treatment of Non–Small-Cell Lung Cancer
- 1 January 2003
- journal article
- Published by Elsevier in Clinical Lung Cancer
- Vol. 4, S68-S73
- https://doi.org/10.3816/clc.2003.s.007
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Protein Kinase C-ε Promotes Survival of Lung Cancer Cells by Suppressing Apoptosis through Dysregulation of the Mitochondrial Caspase PathwayJournal of Biological Chemistry, 2002
- A Phase I trial of h-ras antisense oligonucleotide ISIS 2503 administered as a continuous intravenous infusion in patients with advanced carcinomaCancer, 2001
- Phase III Comparative Study of High-Dose Cisplatin Versus a Combination of Paclitaxel and Cisplatin in Patients With Advanced Non–Small-Cell Lung CancerJournal of Clinical Oncology, 2000
- Phase I trial and pharmacokinetic study of ISIS 5132 combined with carboplatin and paclitaxel for advanced non-small cell lung cancerLung Cancer, 2000
- Tirapazamine Plus Cisplatin Versus Cisplatin in Advanced Non–Small-Cell Lung Cancer: A Report of the International CATAPULT I Study GroupJournal of Clinical Oncology, 2000
- Phase III Trial of Gemcitabine Plus Cisplatin Versus Cisplatin Alone in Patients With Locally Advanced or Metastatic Non–Small-Cell Lung CancerJournal of Clinical Oncology, 2000
- Phase I Evaluation of ISIS 3521, an Antisense Oligodeoxynucleotide to Protein Kinase C-Alpha, in Patients With Advanced CancerJournal of Clinical Oncology, 1999
- Phase I Clinical/Pharmacokinetic and Pharmacodynamic Trial of the c-raf-1 Antisense Oligonucleotide ISIS 5132 (CGP 69846A)Journal of Clinical Oncology, 1999
- Randomized trial comparing cisplatin with cisplatin plus vinorelbine in the treatment of advanced non-small-cell lung cancer: a Southwest Oncology Group study.Journal of Clinical Oncology, 1998
- Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trialsBMJ, 1995